Rakovina Therapeutics Inc RKVTF
Trading Information
- Previous Close Price
- $0.16
- Day Range
- $0.13–0.13
- 52-Week Range
- $0.04–0.32
- Bid/Ask
- $0.09 / $1.29
- Shares Outstanding
- 24.41M
- Market Cap
- $2.79M
- Volume/Avg
- 15,161 / 17,270
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
Valuation
|
Metric
|
RKVTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RKVTF
|
|---|---|
Quick Ratio | 0.10 |
Current Ratio | 0.15 |
Interest Coverage | −13.05 |
Quick Ratio
RKVTF
Profitability
|
Metric
|
RKVTF
|
|---|---|
Return on Assets (Normalized) | −130.80% |
Return on Equity (Normalized) | −2,765.85% |
Return on Invested Capital (Normalized) | −174.10% |
Return on Assets
RKVTF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|C>$?GQB | LOCK|?Z<hp | $131B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|GNm#Q&^ | LOCK|B@@Z% | $80B | |||
| argenx SE ADR
ARGX
| LOCK|@P?%h?t | LOCK|$tD | $62B | |||
| Moderna Inc
MRNA
| LOCK|mtjXGx | LOCK|!f | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>v#HwX | LOCK|@b | $40B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|J^!BpFQ | LOCK|d^qs | $33B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|vvh&^d> | LOCK|?TRT | $26B | |||
| Incyte Corp
INCY
| LOCK|&%rph$r | LOCK|kr | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|H$>WQ@ | LOCK|!& | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|@TzsqqB | LOCK|wwD | $16B |
United States